NCT07866326Recruiting
Prevalence of Adrenal Insufficiency and Associated Factors in Rheumatoid Arthritis Patients Using Low-dose Corticosteroids.
Prevalence of Adrenal Insufficiency and Influencing Factors in Patients With Rheumatoid Arthritis and Using Low-dose Corticosteroids.
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
This study aims to investigate the prevalence of adrenal insufficiency in rheumatoid arthritis (RA) patients receiving low-dose corticosteroid therapy and to identify the factors influencing adrenal insufficiency. To this end, the researchers plan to conduct a study comparing the prevalence of adrenal insufficiency and associated factors among RA patients-who are currently receiving low-dose corticosteroid therapy during outpatient follow-up and have consented to participate-by categorizing them into three groups based on the duration of treatment: short (3 weeks-3 months), medium (3-12 months), and long (\>12 months).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 1 Oct 2026
- Start date
- Jul 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07866326
What you commit to
- Study type: Observational
- Planned participants: 120
- From Jul 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who have received pulse steroid therapy within the last 6 months.
Other illness
- Patients with primary adrenal insufficiency.
- Uncontrolled diabetes mellitus
- Comorbidities; ≥NYHA Class 3 heart failure, Stage 3 chronic kidney failure, ≥Child-Pugh Class B liver cirrhosis
Other
- Pregnancy and lactation.
- Hypopituitarism
Who the study is looking for
- Participants diagnosed with rheumatoid arthritis according to the 2010 ACR/EULAR criteria.
- Participants who have been undergoing corticosteroid treatment for at least 3 weeks.
- Participants in remission or with low disease activity (DAS28-CRP ≤3.2).
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SBU Bursa Yüksek İhtisas EAH Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.